Vaccinex, Inc.
NASDAQ:VCNX
0.76 (USD) • At close April 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.601 | 0.57 | 0.1 | 0.9 | 0.05 | 0.523 | 0.724 | 0.09 | 0.316 |
| Cost of Revenue
| 0 | 0 | 0.207 | 0.169 | 0.002 | 0.199 | 1.033 | 0.16 | 0.115 |
| Gross Profit
| 0.601 | 0.57 | -0.107 | 0.731 | 0.048 | 0.324 | -0.309 | -0.07 | 0.201 |
| Gross Profit Ratio
| 1 | 1 | -1.07 | 0.812 | 0.96 | 0.62 | -0.427 | -0.778 | 0.636 |
| Reseach & Development Expenses
| 12.545 | 16.574 | 13.979 | 17.16 | 21.549 | 25.67 | 22.353 | 16.551 | 16.028 |
| General & Administrative Expenses
| 6.791 | 6.881 | 6.202 | 6.23 | 7.405 | 6.669 | 4.619 | 4.483 | 4.432 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 6.791 | 6.881 | 6.202 | 6.23 | 7.405 | 6.669 | 4.619 | 4.483 | 4.432 |
| Other Expenses
| 0 | 0 | -0.175 | 0.043 | -0.575 | 0.152 | 0.165 | -0.04 | -0.004 |
| Operating Expenses
| 19.336 | 23.455 | 20.006 | 23.39 | 28.379 | 32.339 | 26.972 | 21.034 | 20.46 |
| Operating Income
| -18.735 | -22.885 | -19.906 | -22.49 | -28.331 | -32.015 | -27.281 | -21.104 | -20.259 |
| Operating Income Ratio
| -31.173 | -40.149 | -199.06 | -24.989 | -566.62 | -61.214 | -37.681 | -234.489 | -64.111 |
| Total Other Income Expenses Net
| 0.101 | 2.634 | 0.091 | 0.11 | -0.52 | 0.152 | -2.237 | 2.345 | 6.316 |
| Income Before Tax
| -18.634 | -20.251 | -19.815 | -22.38 | -28.851 | -31.863 | -29.518 | -18.759 | -13.943 |
| Income Before Tax Ratio
| -31.005 | -35.528 | -198.15 | -24.867 | -577.02 | -60.924 | -40.771 | -208.433 | -44.123 |
| Income Tax Expense
| 0 | 0 | -0.093 | 0.852 | 0.458 | 0.152 | -1.845 | 1.281 | 2.986 |
| Net Income
| -18.634 | -20.251 | -19.722 | -23.232 | -29.309 | -32.015 | -29.518 | -18.722 | -13.943 |
| Net Income Ratio
| -31.005 | -35.528 | -197.22 | -25.813 | -586.18 | -61.214 | -40.771 | -208.022 | -44.123 |
| EPS
| -8.88 | -43.68 | -97.59 | -170.04 | -327.62 | -521.95 | -1,186.7 | -689.86 | -526.85 |
| EPS Diluted
| -8.88 | -43.68 | -97.59 | -169.11 | -327.62 | -521.95 | -1,186.7 | -689.86 | -526.85 |
| EBITDA
| -18.735 | -19.748 | -19.606 | -21.402 | -28.055 | -31.614 | -28.903 | -17.195 | -10.775 |
| EBITDA Ratio
| -31.173 | -34.646 | -196.06 | -23.78 | -561.1 | -60.447 | -39.921 | -191.056 | -34.098 |